Biotricity Inc (OTCPK:BTCY)

Q3 2025 Biotricity Inc Earnings Call Transcript

Feb 20, 2025 / 10:30 PM GMT

Release Date Price: $0.644 (-2.42%)

Transcript 8-K10-Q/A10-Q

Key Points

Positve

Biotricity Inc (BTCY) achieved positive free cash flows for the second consecutive quarter, indicating progress towards profitability.
The company reported a 21.7% year-over-year increase in revenue, reaching $3.6 million for the quarter.
Gross profit improved by 27.5% year-over-year, with a gross margin increase to 76.4%, driven by efficiencies and an expanded recurring technology fee revenue base.
Strategic alliances with top group purchasing organizations and specialist organizations are expanding Biotricity Inc (BTCY)'s market reach beyond cardiology.
The company is on the cusp of achieving positive EBITDA, with significant improvements in adjusted EBITDA and free cash flow metrics.

Negative

Despite improvements, Biotricity Inc (BTCY) still reported a net loss attributable to common stockholders of $1.32 million for the quarter.
The company faces high variable interest rates, which impact its financial performance.
Biotricity Inc (BTCY) is still in the process of transitioning its business model, which involves challenges in managing longer sales cycles and larger accounts.
The company's international expansion is opportunistic and dependent on partnerships, which may limit its growth potential outside the United States.
Biotricity Inc (BTCY) is investing heavily in R&D and commercial expansion, which could strain resources if not managed prudently.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BTCY.PK - Biotricity Inc
Q3 2025 Biotricity Inc Earnings Call
Feb 20, 2025 / 10:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings and welcome to Biotricity fiscal 3rd quarter 2025 results release conference call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If want to require operator assistance, please press 0 or your telephone keypad. As a reminder, this call is being recorded. It is now my pleasure to introduce founder and CEO Doctor Wakass Al Sadiq.

Thank you. You may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you everybody for joining us today.

Third quarter 2025 has been a transformative

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.